Press Release Distribution
sildenafil tablets Press Releases
By Dr. Reddy’s Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Sildenafil Tablets (20 mg) a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November16, 2012.
Page updated every 10 minutes